Leukemia Research
Volume 36, Issue 6 , Pages 756-763 , June 2012

Potentiation of Nilotinib-mediated cell death in the context of the bone marrow microenvironment requires a promiscuous JAK inhibitor in CML

  • Rajesh R. Nair

      Affiliations

    • Molecular Oncology Program, H. Lee Moffitt Cancer Center, Tampa, FL, USA
  • ,
  • Joel H. Tolentino

      Affiliations

    • Molecular Oncology Program, H. Lee Moffitt Cancer Center, Tampa, FL, USA
  • ,
  • Raul F. Argilagos

      Affiliations

    • Molecular Oncology Program, H. Lee Moffitt Cancer Center, Tampa, FL, USA
  • ,
  • Ling Zhang

      Affiliations

    • Department of Pathology, H. Lee Moffitt Cancer Center, Tampa, FL, USA
  • ,
  • Javier Pinilla-Ibarz

      Affiliations

    • Hematology Malignancies Program, H. Lee Moffitt Cancer Center, Tampa, FL, USA
  • ,
  • Lori A. Hazlehurst

      Affiliations

    • Molecular Oncology Program, H. Lee Moffitt Cancer Center, Tampa, FL, USA
    • Corresponding Author InformationCorresponding author at: Molecular Oncology Program, H. Lee Moffitt Cancer Center, 12905 Magnolia Dr., Tampa, FL 33612, USA. Tel.: +1 813 903 6807; fax: +1 813 979 7265.

Received 14 October 2011 ,Revised 22 November 2011 ,Accepted 6 December 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(11)00580-7

doi: 10.1016/j.leukres.2011.12.002

Leukemia Research
Volume 36, Issue 6 , Pages 756-763 , June 2012